These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 9081307)
81. Lysosubtilin modification, Fermosorb, designed for polymeric carrier-mediated intestinal delivery of lytic enzymes: pilot-scale preparation and evaluation of this veterinary medicinal product. Biziulevicius GA; Zukaite V Int J Pharm; 1999 Oct; 189(1):43-55. PubMed ID: 10518684 [TBL] [Abstract][Full Text] [Related]
82. Comparative antimicrobial activity of lysosubtilin and its acid-resistant derivative, Fermosorb. Biziulevièius GA; Sukaitë V Int J Antimicrob Agents; 2002 Jul; 20(1):65-8. PubMed ID: 12127714 [TBL] [Abstract][Full Text] [Related]
83. [Lysosubtilin G10x--a new antimicrobial agent for treatment and prophylaxis. Physico-chemical properties]. Biziuliavichius GA; Shablinskas AI; Zhukaĭte VP; Kislukhina OV Antibiot Med Biotekhnol; 1987 May; 32(5):331-3. PubMed ID: 3111353 [TBL] [Abstract][Full Text] [Related]
84. Safety of lysosubtilin per os in mice, rabbits and calves. Biziulevichius GA; Arestov IG Vet Res; 1997; 28(4):385-95. PubMed ID: 9257446 [TBL] [Abstract][Full Text] [Related]
85. Enhancement of lytic enzyme production resulting from replacement of the usual morphological variant of industrial lysosubtilin producer. Biziulevichius GA; Normantiene T Lett Appl Microbiol; 1997 Feb; 24(2):133-5. PubMed ID: 9081307 [TBL] [Abstract][Full Text] [Related]
86. Exploitation of Bacillus subtilis as a robust workhorse for production of heterologous proteins and beyond. Cui W; Han L; Suo F; Liu Z; Zhou L; Zhou Z World J Microbiol Biotechnol; 2018 Sep; 34(10):145. PubMed ID: 30203131 [TBL] [Abstract][Full Text] [Related]
87. Biochemistry, genetics and regulation of bacilysin biosynthesis and its significance more than an antibiotic. Özcengiz G; Öğülür İ N Biotechnol; 2015 Dec; 32(6):612-9. PubMed ID: 25644640 [TBL] [Abstract][Full Text] [Related]